Anti-β2 Glycoprotein I Antibodies Prevent the De-activation of Platelets and Sustain their Phagocytic Clearance
- 31 December 2000
- journal article
- Published by Elsevier BV in Journal of Autoimmunity
- Vol. 15 (4), 469-477
- https://doi.org/10.1006/jaut.2000.0449
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Phosphatidylserine Expression on Cell Surfaces Promotes Antibody-dependent Aggregation and Thrombosis in β2-glycoprotein I-immune MiceJournal of Autoimmunity, 2000
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- Dendritic Cells Preferentially Internalize Apoptotic Cells Opsonized by Anti-β2-glycoprotein I AntibodiesJournal of Autoimmunity, 1998
- Apoptotic cell clearance in systemic lupus erythematosus: II. Role of ?2-glycoprotein IArthritis & Rheumatism, 1998
- Immune Clearance of Phosphatidylserine-expressing Cells by PhagocytesOnline Journal of Public Health Informatics, 1997
- Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.JCI Insight, 1997
- Thrombocytopenia in the antiphospholipid syndromeBritish Journal of Haematology, 1996
- Role of Divalency in the High-Affinity Binding of Anticardiolipin Antibody−β2-Glycoprotein I Complexes to Lipid MembranesBiochemistry, 1996
- Exposure of Anionic Phospholipids upon Platelet Activation Permits Binding of β2 Glycoprotein I and Through it that ofIgG Antiphospholipid Antibodies. Studies in Platelets from Patients with Antiphospholipid Syndrome and Normal SubjectsJournal of Autoimmunity, 1994
- Survival of Blood Platelets Labeled with Chromium5112JCI Insight, 1958